Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.26 | N/A |
PEG Ratio (TTM) | -0.02 | N/A |
P/S Ratio (TTM) | 0.22 | N/A |
P/B Ratio (TTM) | 0.69 | N/A |
P/FCF Ratio (TTM) | -12.95 | N/A |
Price to 5YR AVG Earnings Ratio | -5.48 | N/A |
Price to 5YR AVG FCF Ratio | -9.65 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -9.36% | N/A |
ROE (TTM) | -29.03% | N/A |
Net Profit Margin (TTM) | -9.15% | N/A |
ROIC 5YR AVG | -10.06% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | N/A | -416.69% | 128.01% |
Revenue | N/A | 95.06% | 57.27% |
Net Income | N/A | -456.88% | 102.26% |
Cash Flow | N/A | 360.65% | 243.14% |
Health (25%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.27 | N/A |
Quick Ratio (TTM) | 0.97 | N/A |
D/E Ratio (TTM) | 0.82 | N/A |
Interest Coverage (TTM) | -9.39 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 0.42 | N/A |
LTL to 5YR AVG FCF | -7.71 | N/A |
Shares Outstanding Growth 5YR AVG | 183.40% | N/A |